[Virus infections and pregnancy--what are the risks?].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State; D002690:Chlamydia Infections / Q000188:drug therapy; D003561:Cytarabine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control; D006509:Hepatitis B / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012409:Rubella / Q000175:diagnosis; D012698:Serologic Tests; D014777:Virus Diseases / Q000175:diagnosis / Q000517:prevention & control; D005719:gamma-Globulins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D006510:Hepatitis B Antibodies; D005719:gamma-Globulins; D003561:Cytarabine
Virusinfektionen und Schwangerschaft--welche Risiken?